I initially thought the phase 2/3b trial was our b
Post# of 148292
(Total Views: 553)
Posted On: 04/30/2020 7:54:23 PM
I initially thought the phase 2/3b trial was our best chance to yield (interim) results that could potentially lead to early approval but with the sluggish enrollment, it may very well be the phase 2 mild to moderate that completes first.
Does anyone here have the latest enrollment count for either? With the phase 2, I believe it's just 75 patients, the "treatment window" is 6 weeks but I never heard of any plan for interim results being reviewed. Is there any reason why this is and could this be changed?
Does anyone here have the latest enrollment count for either? With the phase 2, I believe it's just 75 patients, the "treatment window" is 6 weeks but I never heard of any plan for interim results being reviewed. Is there any reason why this is and could this be changed?
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼